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Purpose. Strategies for volume assessment of critically ill patients are limited, yet early goal-directed therapy improves outcomes.
Central venous pressure (CVP), Bioimpedance Vectorial Analysis (BIVA), and brain natriuretic peptide (BNP) are potentially
useful tools. We studied the utility of these measures, alone and in combination, to predict changing oxygenation. Methods.
Thirty-four mechanically ventilated patients, 26 of whom had data beyond the ﬁrst study day, were studied. Relationships were
assessed between CVP, BIVA, BNP, and oxygenation index (O2I) in a cross-sectional (baseline) and longitudinal fashion using
both univariate and multivariable modeling. Results. At baseline, CVP and O2I were positively correlated (R = 0.39; P = .021),
while CVP and BIVA were weakly correlated (R =− 0.38; P = .025). The association between slopes of variables over time was
negligible, with the exception of BNP, whose slope was correlated with O2I( R = 0.40; P = .044). Comparing tertiles of CVP,
BIVA, and BNP slopes with the slope of O2I revealed only modest agreement between BNP and O2I (kappa = 0.25; P = .067).
In a regression model, only BNP was signiﬁcantly associated with O2I; however, this was strengthened by including CVP in the
model. Conclusions. BNP seems to be a valuable noninvasive measure of volume status in critical care and should be assessed in a
prospective manner.
1.Purpose
Volume assessment and management in critically ill patients
remains challenging [1]. Issues of timing, choice, amount
of ﬂuids, and type of volume assessments to guide therapy
continue to be investigated. While early volumeresuscitation
and goal-directed therapy have been shown to improve
mortality and morbidity [2, 3] and lessen the risk of acute
kidney injury [3], management of patients with established
acute lung injury reveals that a more conservative or “dry”
strategy is more appropriate than a liberal or “wet” one
[4]. Studies of the assessment of ﬂuid status have shown
that simple central venous pressure (CVP) monitoring is
as eﬀective, and safer, than more invasive means such as
pulmonary artery occlusion pressure [5]. It is clear, however,
that CVP does not tell the entire story, as patients with high
right sided pressures may havereduced,normal, orincreased
eﬀective circulating volume.
Bioimpedance vectorial analysis (BIVA) allows determi-
nation of extracellular ﬂuid volume and total body water
from measurements of resistivity of tissues to single or
multifrequency emitted signals. BIVA has been used to2 International Journal of Nephrology
manage volume in hemodialysis patients for several decades.
However, the use of BIVA in critically ill patients has not
been extensively studied, and the data used to determine
volume status have been derived from hemodynamically
stable patients [6, 7].
Brain natriuretic peptide (BNP) is a biomarker used to
identify patients with ﬂuid overload and congestive heart
failure [8]. In critical care, it has been shown to correlate
with mortality and morbidity, though it has not been used
to guide therapy [9, 10].
We conducted a pilot study to examine the relationships
between CVP, BIVA, and BNP in order to determine which
measure,orcombinationofmeasures, relatetovolumestatus
in critically ill, ventilated patients.
2.Methods
This study was approved by the Institutional Review Board
of the San Bortolo Hospital, Vicenza, Italy, and conducted in
the Intensive Care Unit (ICU). Any adult patient requiring
mechanical ventilation was eligible. Because of the technical
requirements for BIVA, patients with any upper or lower
limb amputation, severe rhabdomyolysis, or erysipelas of
both upper or lower limb were excluded. As the study
required serial measurements over time, any patient not
expected to survive 72–96 hours was excluded. Any patient
with recent cardiac surgery was also excluded, as BNP
and CVP may be grossly skewed. Likewise, patients with
decompensated heart failure or acute coronary syndrome
were excluded. As published, BIVA vectors were derived in
Caucasians [6], we excluded non-Caucasians. A sample size
of 30–40 patients was enrolled without formal sample-size
calculations.
Within 48–72 hours of initiating mechanical ventilation,
baseline assessment was undertaken including CVP, BIVA,
and blood sample for BNP, hematocrit, and creatinine. BNP
was determined using Triage MeterPro (Biosite Inc., San
Diego, CA). CVP and BIVA were recorded in a blinded
fashion by separate trained observers. CVP was obtained
through a central venous catheter connected to a calibrated
transducer using the level of the right atrium as a reference
point.BIVAwasperformed using aplethysmographemitting
800-μA and 50-kHz alternating sinusoidal current (EFG
Electroﬂuidgraph, Akern s.r.l., Pontassieve, Florence, Italy)
and previously published methods [11]. Clinical data were
recorded, including primary illness, systolic blood pressure
(SBP),diastolicbloodpressure(DBP),meanarterialpressure
(MAP), heart rate (HR), weight, urine output, pressor
doses, PO2,F i O 2, and mean airway pressure. Additional
measurements were made at 24 and 48 hour intervals to
minimize diurnal variation in BNP. The ﬂuid balance in the
intervening period was calculated.
CVP was categorized as “low” (<4cm H 2O), “high”
(≥14cm H2O), or “normal” (4–14cm H2O) [4]. For the
BIVA, three patterns were considered according to published
references for resistance/height (R/H) based on normals,
adjusted for age, sex, and weight [7]: long vectors outside
the 75% tolerance ellipse (upper pole of the target) were
categorized as “dehydrated” and short vectors outside the
75% tolerance ellipse (lower pole of the target) as “hyper-
hydrated”, while the remainder were “normohydrated”. BNP
was considered as a continuous variable and also divided
into tertiles. Oxygenation index (O2I) was calculated as the
mean airway pressure divided by the ratio of PO2/FiO2 and
multiplied by 100 [4], and the result was then divided into
tertiles.
Using least-squares regression, measures of CVP over
time were used to estimate slope, and ΔCVP was categorized
as “falling” (<−2cm/24h), “rising” (>2cm/24h),or“stable”
(ΔCVP from −2 to 2cm/24h). BIVA change over time was
estimated as the slope of R/H by time, and >30ohm/m/day
was categorized as “falling ECF”; <−30ohm/m/day was “ris-
ingECF”,andvalueswithin ±30ohm/m/daywereconsidered
“stable ECF”. Absolute values of BNP were used to estimate
slope of BNP, and these slopes were divided into tertiles.
Slope of O2I was grouped into tertiles. In the event that a
patientwasextubated,thelastavailablemeanairwaypressure
was carried forward, and the most recent arterial blood gas
values were used to estimate the O2I for the purpose of
calculating the slope.
The agreement between slopes of CVP, BIVA, and BNP
against O2I were estimated using Kappa statistics. Univariate
correlations were assessed at baseline for O2I, CVP, BIVA,
and BNP. Slopes of change were also assessed between these
variables and hemodynamic parameters, ﬂuid balance, and
other clinical parameters such as hematocrit and creatinine.
Multiple linear regression was performed with O2Ia n dΔO2I
as continuous dependent variables.
3.Results
Thirty-four patients were enrolled in the study, 22 (64.7%)
were male, and the most common admitting diagnosis was
trauma, in 12 (35.3%). Remaining baseline characteristics
are presented in Table 1. The majority of patients were
not on pressors or inotropes at baseline, and the mean
noradrenaline dose was 0.007±0.004μcg/kg/min;dopamine
was 1.6 ± 0.5μcg/kg/min. In cross-sectional analysis at
baseline, there was no relationship between tertiles of CVP,
BIVA or BNPwith O2I; however, a weak correlation could be
demonstrated between the continuous variables of CVP and
O2I( R = 0.39; P = .021) (see Figure 1) and a weak negative
correlation between CVP and BIVA (R =− 0.38; P = .025).
Twenty-six subjects had data available beyond the ﬁrst
study day to allow estimation of slopes of change of CVP,
B I V A ,B N P ,a n dO 2I. For these subjects, mean slope of
change of CVP was 0.03mmHg/day, slope of BIVA was
−6.1ohm/m/day, slope of BNP was 60.3pg/mL/day and
slope of O2I was 0.12 per day.
Comparing tertiles of CVP, BIVA, and BNP slopes with
the slope of O2I revealed modest agreement between BNP
and O2I (kappa = 0.25; P = .067) and no agreement
betweentheothervariables.Therelationshipbetweentertiles
of BNP and O2I slope is depicted in Figure 2. Similarly,
using Spearman correlation, the slope of BNP was weakly
correlated with O2I( R = 0.40; P = .044) as shown in
Figure 3. In a regression model examining all of the baseline
variables and slopes of CVP, BIVA, and BNP as potentialInternational Journal of Nephrology 3
Table 1: Baseline characteristics (N = 34).
Clinical variable Mean Standard error
Age (years) 59.2 3.6
SOFAa score day 1 7.1 0.4
CVP (cm H2O) 10.4 0.6
Resistance by height
(ohm/m) 262.3 14.4
BNP (pg/mL) 451.1 119.3
Hematocrit 0.32 0.01
Creatinine (mg/dL) 1.36 0.22
Systolic BP (mmHg) 132.8 4.5
Diastolic BP (mmHg) 58.1 2.0
Heart Rate (beats per
minute) 82.3 3.5
Mean Arterial Pressure
(mmHg) 89.9 2.8
PEEP (mmHg) 9.3 0.5
Mean Airway Pressure
(mmHg) 14.4 0.6
P/F ratio 288.4 18.8
Oxygenation index 5.8 0.5
aSequential Organ Failure Assessment score.
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Figure 1: Correlation (with 95% conﬁdence intervals) between
baseline CVP and Oxygenation Index (R = 0.39; P = .021).
variables, only BNP was signiﬁcantly associated with O2I,
and this was strengthened by including CVP in the model.
Foreach tertile increase inthe slope ofBNP, O2Ii n c r e a s e db y
1.29 (95% CI 0.18–2.41; P = .025).
4.Conclusions
Thisistheﬁrst studyattemptingtoﬁnd themostappropriate
combination of minimally invasive bedside tools for volume
assessment in critically ill patients requiring mechanical ven-
tilation. While none of the markers at baseline, individually
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categorized according to tertile of slope of change of BNP. Absolute
diﬀerence between highest and lowest tertile 2.05 ± 1.04, P = .067
(ANOVA).
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Figure 3: Correlation (with 95% conﬁdence intervals) between
slope of BNP and slope of OxygenationIndex (R = 0.40; P = .044).
or in combination, were helpful in predicting those subjects
whose oxygenation would improve or worsen, we identiﬁed
that changes in BNP over time were correlated with impor-
tant changes in O2I. Furthermore, there was some indication
that combining CVP and BNP in multivariable modeling
further strengthened the latter variable’s association with
change in O2I.
It is intuitive to think that measures of volume, be
they measures of intravascular or extravascular (interstitial)
volume, would be related to lung function and oxygenation.
For instance, animal studies have shown that ﬂuid balance
can inﬂuence both the onset and resolution of severe “high-
permeability” pulmonary edema [12, 13]. Excess extravascu-
lar lung water is a feature of all types of pulmonary edema4 International Journal of Nephrology
[14], and lower extravascular lung water correlates with
ﬂuid balance, decreased ventilator days, and ICU length of
stay [15]. We chose CVP since local practice was such that
most mechanically ventilated patients had central venous
access appropriate for measurement of CVP. Furthermore,
studies indicate a high level of agreement between clinical
measures such as the external jugular pressure and the CVP
[16]; hence, a ready estimate of CVP would be available
in all subjects. We chose BIVA for its ease of use and
noninvasive nature and its ability to provide an estimate of
extravascularwater.BNPwaschosenforitsabilitytorespond
to myocardial stretch [17] and its utility in previous studies
as a predictor of outcome [9, 10].
We did not ﬁnd the addition of measures of BIVA to help
in the ﬂuid assessment of our cohort of patients. Previously,
Piccoli and colleagues [6] demonstrated a modest degree
of inverse correlation between CVP and impedance vector
components, though this was stronger in the group that had
signiﬁcantly elevated CVP and weaker in the group with
lower CVP. These authors suggested that the combination
of CVP and BIVA might be useful in the volume assessment
and management of critically ill patients. We were unable to
demonstrateanycorrelationbetweenBIVAandCVP,norwas
the combination predictive of oxygenation. The principle
diﬀerence between our study and that of Piccoli is that
the minority of patients in the latter study were receiving
mechanical ventilation, while this was a requirement for
eligibility in our study. This may have played a role since
mechanical ventilation with positive end-expiratory pressure
(PEEP) likely and systematically elevated the CVP and
possibly weakened any potential relationship between CVP
and BIVA. Moreover, all the patients in our study had
relatively high values of PEEP (8–10cmH2O).
We were able to demonstrate that change in BNP
was associated with change in O2I, and this relationship
was strengthened modestly in multivariable regression by
including slope of change of CVP. The choice of O2Ia s
an outcome may be justly criticized as a surrogate, but the
study population was not large enough for us to predict
more clinically important outcomes such as lung injury
scores, length of ICU stay, or days of mechanical ventilation,
for example. However, O2I has been shown to be strongly
associated with these more important outcomes in the
Acute Respiratory Distress Syndrome (ARDS) clinical trials
network study [4]. Another limitation of the study is that
the methods used to assess volume were not compared
against other methods such as echocardiography, ultrasound
of the inferior vena cava, pulse pressure variation, or strove
volume variation. This is a fair criticism; however, the study
presented isthe ﬁrst in a series ofpilotendeavours,theintent
of which is to examine varying combinations of volume
assessment. Additional studies utilizing the FloTrac Sensor
and Vigileo Monitor (Edwards Lifesciences, S.A., Saint-Prex
Switzerland) to measure stroke volume variation in critically
ill patients in our institution are underway.
A larger study would have allowed us to explore
more extreme values with greater conﬁdence. For instance,
inspection of the ﬁgures reveals greater variability at the
extremes,andalargersamplesize wouldhaveallowedamore
sophisticated analysis of the relationships to see if nonlinear
modeling would have provided a tighter ﬁt with the data.
An additional limitation is the patient population, in
whom the predominant admitting diagnosis was trauma
(approximatelyonethird).Whiletheremainderhadavariety
of conditions including respiratory failure, decreased level of
consciousness, sepsis, andintracranial hemorrhage orstroke;
generalizability to the critical care population as a whole is
diﬃcult. Another potential limitation relates to ourchoice of
waiting for48–72hourstoenroll patients,duringwhich time
theycouldhavestabilizedtoapointthatmayhavedampened
the strength of the relationships we observed.
Our results are consistent with the recent work of Levitt
and colleagues [18], who carried out a similar prospective
cohort study of critically ill patients and compared various
measures of volume status. As in their study, we found no
relationship between CVP and BNP over time. However,
our study diﬀers in that we examined the combination
of these parameters in multivariable modeling and found
them to provide complementary information in predicting
improvements in oxygenation.
In summary, bedside measures of volume status, CVP
and BIVA, were unhelpful alone in predicting favorable
changes in O2I, while changes in BNPover time did correlate
withchangesinO2I.Therewassomeindicationthatcombin-
ing CVP and BNP improved the ability to predict change in
O2I.Whetherornotinterventionstooptimize bothCVPand
BNPwill resultinimprovedoutcomesinventilated,critically
ill patients will require further prospective study.
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